-transparent.png){kind=logo}
Pyruvate kinase (ATP: pyruvate 2-O-phosphotransferase, EC 2.7.1.40) from human liver and red cells has been purified to homogeneity; its subunit structure and some of its kinetic characteristics have been studied. The influence of a partial proteolysis by trypsin on the subunit structure, the isozymic pattern and the kinetic characteristics of red cell and liver enzyme have been investigated. From the results of this study we may conclude that: 1. Liver (L-type) pyruvate kinase is composed of 4 identical L subunits while the major form of erythrocyte enzyme (PK-R2) is a heterotetramer designated as L2L2', the molecular weight of L' being slightly higher than that of L subunits (63 000 and 58 000 respectively). Pyruvate kinase PK-R1, predominant in the erythroblasts and the young red cells, is composed of four identical L' subunits. 2. A mild tryptic attack is able to transform PK-R1 into PK-R2, then PK-R2 into pyruvate kinase L (PK-L). The same proteolytic treatment transforms the L' subunits into L ones. 3. Consequently L-type pyruvate kinase seems to be initially synthesized in the erythroid precursors as an L4' enzyme secondarily partially proteolysed into L2L2'. In liver a very active proteolytic system would be responsible for the total transformation into L4 pyruvate kinase. 4. L4' enzyme exhibits Michaelis-Menten kinetic behaviour with an apparent Michaelis constant of 3.8 mM whereas L4 enzyme shows both positive and negative homotropic interactions towards phosphoenolpyruvate and has [S] 0.5 of 1.2 mM. The characteristics of L2L2' are roughly intermediate between those of L4' and of L4. Fructose 1,6-biphosphate decreases [S]0.5 for these three pyruvate kinase forms without suppressing the differences in the apparent affinity for phosphoenolpyruvate of these enzymes. 5. L4 pyruvate kinase is more inhibited by Mg-ATP than L4', with L2L2' in the intermediate range. 6. Tryptic treatment of each enzyme form studied transforms its kinetic behaviour into that observed for L4.
A Kahn, and
J Marie, and
H Garreau, and
E D Sprengers
January 1973,
Biochimica et biophysica acta,
A Kahn, and
J Marie, and
H Garreau, and
E D Sprengers
June 1968,
The Journal of biological chemistry,
A Kahn, and
J Marie, and
H Garreau, and
E D Sprengers
February 1978,
Biochemical and biophysical research communications,
A Kahn, and
J Marie, and
H Garreau, and
E D Sprengers
January 1986,
Comparative biochemistry and physiology. B, Comparative biochemistry,
A Kahn, and
J Marie, and
H Garreau, and
E D Sprengers
January 1975,
Biokhimiia (Moscow, Russia),
A Kahn, and
J Marie, and
H Garreau, and
E D Sprengers
January 1977,
Voprosy meditsinskoi khimii,
A Kahn, and
J Marie, and
H Garreau, and
E D Sprengers
February 1979,
Blut,
A Kahn, and
J Marie, and
H Garreau, and
E D Sprengers
August 1974,
European journal of biochemistry,
A Kahn, and
J Marie, and
H Garreau, and
E D Sprengers
February 1981,
Biokhimiia (Moscow, Russia),
A Kahn, and
J Marie, and
H Garreau, and
E D Sprengers
January 1976,
Biochemical Society transactions,
